Ticker

No recent analyst price targets found for CLRO.

Latest News for CLRO

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ClearOne, Inc. (NYSE: CLRO)

NEW YORK, July 9, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating ClearOne, Inc. (NYSE: CLRO ) related to…

PRNewsWire • Jul 9, 2026
CLRO Stock Alert: Halper Sadeh LLC is Investigating Whether ClearOne, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the merger of ClearOne, Inc. (NYSE: CLRO) and Cortigent, Inc. Upon closing of the Proposed Transaction, ClearOne shareholders will own 12.7% to 14.4% of the outstanding equity in the combined company.Halper Sadeh encourages ClearOne shareholders to click here to learn more about their rights and options or contact Daniel Sadeh…

Business Wire • Jul 6, 2026
ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical

SALT LAKE CITY--(BUSINESS WIRE)--ClearOne, Inc. (Nasdaq: CLRO) (“ClearOne”) announced today that it has entered into a definitive agreement and plan of merger (the “Agreement”) among its wholly-owned subsidiary (“MergerSub”), Vivani Medical, Inc. (Nasdaq: VANI; “Vivani”), and Cortigent, Inc. (“Cortigent”), a wholly-owned subsidiary of Vivani, pursuant to which Cortigent will become a wholly-owned subsidiary of…

Business Wire • Jul 2, 2026
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani proposes to merge Cortigent, Inc. with a wholly owned subsidiary of ClearOne, Inc. (Nasdaq: CLRO), and change the listed company's name and ticker to Cortigent Holdings, Inc. (d/b/a Cortigent) and "CRGT" Cortigent is a leading developer of brain computer interface ("BCI") devices based on precision neurostimulation technology ALAMEDA, Calif.

Globe News Wire • Jul 2, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CLRO.

No House trades found for CLRO.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top